Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Comparative Pharmacology of Ofatumumab vs Ocrelizumab in Humanized CD20 Transgenic Mice

              Author:Bigaud, Marc   Anthony, Daniel   Zipfel, Geraldine   Uffelmann, Tatjana   Vostiarova, Helena   Engelhardt, Volker   Nuesslein-Hildesheim, Barbara   Kieseier, Bernd   

              Session Name:S9: MS Biomarkers, Immunology, and Basic Science  

              Topic:MS and Inflammatory Disease  

              Program Number:S9.007  

              Author Institution:Novartis Pharma AG, Basel, Switzerland  University of Oxford, Oxford, United Kingdom